Login
$BCYC
$3.78 +$0.13 (3.56%) Close

Company Executives

$BCYC Management Team

Mr. Felix Baker

Non-Executive Independent Chairman of the Board

Age 56
Compensation $658.3K USD
Sex Male

Mr. Travis Thompson

Chief Financial Officer

Age 46
Compensation -
Sex Male

Dr. Kevin Lee

Chief Executive Officer

Executive Director

Age 56
Compensation $4.857M USD
Sex Male

Mr. Alistair Milnes

Chief Operating Officer

Age 51
Compensation $2.592M USD
Sex Male

Dr. Michael Skynner

Chief Technology Officer

Age 56
Compensation $3.075M USD
Sex Male

Mr. Michael Hannay

Chief Product and Supply Chain Officer

Age 59
Compensation $2.365M USD
Sex Male

Mr. Eric Westin

Chief Medical Officer

Age 73
Compensation -
Sex Male
Directors
10
serving now
Independent
8 of 10
stated in the proxy
Average tenure
1.5 years
from year joined
CEO also chairs the board
No
Felix Baker
Director Age On board Independent Committees Other public boards Pay Source
Felix Baker
Not stated 2024
2 years
Independent
Nominating and Corporate Governance Committee
None stated Not stated
Hervé Hoppenot
Not stated 2025
1 year
Independent
Audit Committee Compensation Committee
Maze Therapeutics, Inc. Not stated
Kevin Lee
Not stated Not stated Not independent None stated None stated Not stated
Jose-Carlos Gutierrez-Ramos
Not stated Not stated Independent
Compensation Committee
None stated Not stated
Charles Swanton
Not stated Not stated Not independent None stated None stated Not stated
Roger Dansey
Not stated Not stated Independent None stated None stated Not stated
Alessandro Riva
Not stated Not stated Independent None stated None stated Not stated
Stephen Sands
Not stated Not stated Independent None stated None stated Not stated
Janice Bourque Leaving at the meeting
Not stated Not stated Independent
Nominating and Corporate Governance Committee
None stated Not stated
Gregory Winter Leaving at the meeting
Not stated Not stated Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

5 disclosed in the proxy filed Apr 22, 2026
Pierre Legault
former Chairman of our Board; President, Treasurer and Director of Stone Atlanta Estates LLC
$0.1 million and $0.2 million
years ended December 31, 2025 and December 31, 2024

Consultancy services provided to the company through Stone Atlanta under a consultancy agreement

With Stone Atlanta Estates LLC Open in proxy
Pierre Legault
former Chairman of our Board; President, Treasurer and Director of Stone Atlanta Estates LLC
$0.2 million
2024

Additional fee awarded by the Board in recognition of extra time commitment in 2024

With Stone Atlanta Estates LLC Open in proxy
667, L.P. and Baker Brothers Life Sciences, L.P.
entities affiliated with Baker Bros. Advisors LP, an entity which may be deemed a beneficial owner of greater than 10% of our voting securities
$366.6 million
2024

Purchase of non-voting ordinary shares in the Private Placement at $21.42 per share

Deep Track Capital LP
may be deemed a beneficial owner of greater than 5% of our voting securities
$44.0 million
2024

Purchase of non-voting ordinary shares in the Private Placement

each of our directors and officers
directors and officers of the company
Amount not stated

Deeds of indemnity under which the company agreed to indemnify directors and executive officers to the fullest extent permitted by law

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support